Funded Tech Companies
Satsuma Pharmaceuticals
Looking for the VC firms that provided funding to Satsuma Pharmaceuticals? Shin Nippon Biomedical Laboratories, CAM Capital and TPG Biotech joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Satsuma Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 Oyster Point Blvd. 221
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Satsuma Pharmaceuticals (Nasdaq: STSA) is focused on developing best-in-class products to address the unmet needs of migraine sufferers.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/12/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Kollins
Chief Financial Officer
Thomas O'Neil
Chief Medical Officer
Detlef Albrecht
Vice President
Robert Schultz
VP - Operations
Mic Iwashima
VP - Regulatory Affairs
Shannon Strom
Company Investors
- Shin Nippon Biomedical Laboratories
- CAM Capital
- TPG Biotech (Heath Lukatch)
- SBI Investment Korea
- Wellington Management Company
- Osage Partners
- RA Capital (Rajeev Shah)
- Lumira Capital
- Cormorant Asset Management
- Eventide Asset Management
- Surveyor Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs